188 related articles for article (PubMed ID: 23810810)
1. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
[TBL] [Abstract][Full Text] [Related]
2. High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis.
Thummarati P; Wijitburaphat S; Prasopthum A; Menakongka A; Sripa B; Tohtong R; Suthiphongchai T
World J Gastroenterol; 2012 Jan; 18(3):244-50. PubMed ID: 22294827
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein-6 suppresses TGF-β
Liu X; Liu M; Ji M; Ma B; Hou YC; Yao XY; Cheng QC; Chen L
Int J Ophthalmol; 2024; 17(4):646-652. PubMed ID: 38638261
[TBL] [Abstract][Full Text] [Related]
4. TGF-β2-induced alterations of m6A methylation in hTERT RPE-1 cells.
Li X; Zhao X; Yin R; Yuan M; Zhang Y; Li X
Exp Eye Res; 2024 Apr; 241():109839. PubMed ID: 38395214
[TBL] [Abstract][Full Text] [Related]
5. Arginase-1 promotes lens epithelial-to-mesenchymal transition in different models of anterior subcapsular cataract.
Li Q; Wang Y; Shi L; Wang Q; Yang G; Deng L; Tian Y; Hua X; Yuan X
Cell Commun Signal; 2023 Sep; 21(1):236. PubMed ID: 37723490
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a/β-catenin-mediated epithelial-mesenchymal transition: a key driver of subretinal fibrosis in neovascular age-related macular degeneration.
Liu D; Du J; Xie H; Tian H; Lu L; Zhang C; Xu GT; Zhang J
J Neuroinflammation; 2024 Mar; 21(1):75. PubMed ID: 38532410
[TBL] [Abstract][Full Text] [Related]
7. A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.
Hillig T; Engelholm LH; Ingvarsen S; Madsen DH; Gårdsvoll H; Larsen JK; Ploug M; Danø K; Kjøller L; Behrendt N
J Biol Chem; 2008 May; 283(22):15217-23. PubMed ID: 18362146
[TBL] [Abstract][Full Text] [Related]
8. Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer.
Montuori N; Pesapane A; Rossi FW; Giudice V; De Paulis A; Selleri C; Ragno P
Transl Med UniSa; 2016 Nov; 15():15-21. PubMed ID: 27896223
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04.
Yang Y; Ye Y; Lin X; Wu K; Yu M
PLoS One; 2013; 8(2):e56837. PubMed ID: 23437252
[TBL] [Abstract][Full Text] [Related]
10. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
Bernstein AM; Twining SS; Warejcka DJ; Tall E; Masur SK
Mol Biol Cell; 2007 Jul; 18(7):2716-27. PubMed ID: 17507651
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Connective Tissue Growth Factor Expression in Adult Retinal Pigment Epithelial-19 Cells by Blocking Yes-Associated Protein/Transcriptional Coactivator with PDZ-Binding Motif Activity.
Murakami Y; Imaizumi T; Hashizume K; Tezuka Y; Oku Y; Nishiya N; Sanbe A; Kurosaka D
J Ocul Pharmacol Ther; 2024 May; 40(4):246-252. PubMed ID: 38517736
[No Abstract] [Full Text] [Related]
12. Inhibition of TGF-β2-induced migration and epithelial-mesenchymal transition in ARPE-19 by sulforaphane.
Huang YB; Liu PP; Zheng H; Yang XX; Yang CC; Liu Y; Liu Y
Int J Ophthalmol; 2021; 14(7):973-980. PubMed ID: 34282380
[TBL] [Abstract][Full Text] [Related]
13. Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.
Bhandary YP; Velusamy T; Shetty P; Shetty RS; Idell S; Cines DB; Jain D; Bdeir K; Abraham E; Tsuruta Y; Shetty S
Am J Respir Crit Care Med; 2009 Feb; 179(4):288-98. PubMed ID: 19029002
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal Transition (EMT) and the Effect of Atorvastatin on it in ARPE-19 cells.
Mysore Y; Hytti M; Deen AJ; Ranta-Aho S; Piippo N; Toppila M; Loukovaara S; Harju N; Kauppinen A
Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38777991
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator promotes corneal epithelial migration and nerve regeneration.
Sugioka K; Nishida T; Kodama-Takahashi A; Murakami J; Fukuda M; Matsuo O; Kusaka S
Exp Eye Res; 2023 Aug; 233():109559. PubMed ID: 37385532
[TBL] [Abstract][Full Text] [Related]
16. Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.
Wang S; Jiang L; Han Y; Chew SH; Ohara Y; Akatsuka S; Weng L; Kawaguchi K; Fukui T; Sekido Y; Yokoi K; Toyokuni S
Oncotarget; 2016 Oct; 7(43):69565-69578. PubMed ID: 27602956
[TBL] [Abstract][Full Text] [Related]
17. Palmitic acid promotes human retinal pigment epithelial cells migration by upregulating miR-222 expression and inhibiting NUMB.
Li F; Lei C; Gong K; Bai S; Sun L
Aging (Albany NY); 2023 Apr; 15(18):9341-9357. PubMed ID: 37566749
[TBL] [Abstract][Full Text] [Related]
18. Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity.
Chang JW; Kang SU; Shin YS; Kim KI; Seo SJ; Yang SS; Lee JS; Moon E; Lee K; Kim CH
PLoS One; 2014; 9(3):e92198. PubMed ID: 24667444
[TBL] [Abstract][Full Text] [Related]
19. Urokinase-Type Plasminogen Activator Receptor Regulates Prosurvival and Angiogenic Properties of Cardiac Mesenchymal Stromal Cells.
Dergilev K; Tsokolaeva Z; Goltseva Y; Beloglazova I; Ratner E; Parfyonova Y
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958542
[TBL] [Abstract][Full Text] [Related]
20. A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.
Nieves EC; Manchanda N
J Biol Chem; 2010 Apr; 285(17):12595-603. PubMed ID: 20177061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
